Status:
UNKNOWN
Immunomediated Non-alcoholic SteaTohepatitis; Prevalence and Characterization. INSTInCT Study
Lead Sponsor:
Instituto de Investigación Marqués de Valdecilla
Collaborating Sponsors:
Hospital Universitario La Fe
Puerta de Hierro University Hospital
Conditions:
Main Hypothesis is That in the NASH Associated to IMIDs, to Different Phenotypes co Exist
Eligibility:
All Genders
18+ years
Brief Summary
NAFLD is a common comordidity in patients with IMID, including inflammatory bowel disease and psoriasis. Nevertheless, the prevalence of NAFLD and NASH in the IMID population is not clear, and the ri...
Eligibility Criteria
Inclusion
- NAFLD with biopsy proven disease above 18 years
- IMID patients above 18 years
- All participants must give informed written consent
Exclusion
- Patients who had any clinical evidence of malignancy
- Other secondary cause of chronic liver disease. Alternative causes of liver disease included excessive alcohol intake (higher than 20 g/day in women and 30 g/day in men), viral hepatitis, chronic alcohol consumption, autoimmune hepatitis, Wilson´s disease, alpha-1-antitripsine deficiency, inborn errors of metabolism or drug induced liver injury
Key Trial Info
Start Date :
January 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
7300 Patients enrolled
Trial Details
Trial ID
NCT03760172
Start Date
January 7 2019
End Date
December 31 2021
Last Update
November 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario Marques de Valdecilla
Santander, Cantabria, Spain, 39008